CoChat

Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage

Open access

The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.

Abstract

Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0099649

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Scheme of phiC31-int mediated recombination in bacterial host. PhiC31 integrase performs precise recombination between an attB site located in the Streptomyces genome and an attP site located on the phiC31 phage genome. The outcome is integration of the phage into the host genome.
Figure 1 Scheme of phiC31-int mediated recombination in bacterial host. PhiC31 integrase performs precise recombination between an attB site located in the Streptomyces genome and an attP site located on the phiC31 phage genome. The outcome is integration of the phage into the host genome.CC BY · PubMed Central
Figure 2 Analysis of cell lines which constitutively expressed phiC31-int. A) PhiC31 RT-PCR on three different cell lines. HFi and Hi16 are derived from Hela cell line and TC1 from NIH-3T3 cell line. Control condition lane lacks RNA. B) PCR which detects LTR junctions or intact attB sites after transduction with a NILV attB-CMV-Neo.
Figure 2 Analysis of cell lines which constitutively expressed phiC31-int. A) PhiC31 RT-PCR on three different cell lines. HFi and Hi16 are derived from Hela cell line and TC1 from NIH-3T3 cell line. Control condition lane lacks RNA. B) PCR which detects LTR junctions or intact attB sites after transduction with a NILV attB-CMV-Neo.CC BY · PubMed Central
Figure 3 Analysis strategies to detect the specific integrations mediated by phiC31-int. A) Illustration of the three mechanisms of the phiC31-int mediated integration of a NILV containing an attB sequence. According to the type of integration, the PCR results in three different profiles: - PCRs LTR+/attB− : integration type (1), specific integration. - PCRs LTR−/attB+: integration type (2), residual integration. - PCRs LTR+/attB+: integration type (3), illegitimate integration. P1/P1′ are the primers used for attB PCR and P2/P2′ are the primers used for LTR PCR. B) Schematic representations of the inverse PCR and the adapted inverse PCR strategies used to characterize phiC31-int integration sites.
Figure 3 Analysis strategies to detect the specific integrations mediated by phiC31-int. A) Illustration of the three mechanisms of the phiC31-int mediated integration of a NILV containing an attB sequence. According to the type of integration, the PCR results in three different profiles: - PCRs LTR+/attB− : integration type (1), specific integration. - PCRs LTR−/attB+: integration type (2), residual integration. - PCRs LTR+/attB+: integration type (3), illegitimate integration. P1/P1′ are the primers used for attB PCR and P2/P2′ are the primers used for LTR PCR. B) Schematic representations of the inverse PCR and the adapted inverse PCR strategies used to characterize phiC31-int integration sites.CC BY · PubMed Central
Figure 4 DNA sequence of att and pattP sites. A) Wild type attP and attB sites. After recombination two hybrids sites are formed: attL and attR. B) Recombination between attB site and the human locus Xq22.1 This recombination generates a pattR which has been isolated by inverse PCR. Xq22.1 had been described previously as a human pattP by MP Calos et al., who isolated the same pattR.
Figure 4 DNA sequence of att and pattP sites. A) Wild type attP and attB sites. After recombination two hybrids sites are formed: attL and attR. B) Recombination between attB site and the human locus Xq22.1 This recombination generates a pattR which has been isolated by inverse PCR. Xq22.1 had been described previously as a human pattP by MP Calos et al., who isolated the same pattR.CC BY · PubMed Central
Figure 5 Detection of recombination mediated by phiC31-int between an attB site contained into a NILV and a genomic attP site. A) Scheme of the DsRed2 PCR before and after the enzymatic restriction treatment. B) PCR DsRed2 results without restriction enzyme treatment. Lanes 1 to 3: cotransduction with CMV-Neo and CMV-PhiC31 increasing vector input of 50–150–300 ng of p24. Lanes 4 to 6: cotransduction with attB-CMV-Neo and CMV-PhiC31 increasing vector input of 50–150–300 ng of p24. Lane 7: attB-CMV-Neo. Lane 8: positive control generated by triple-transfection (CMV-phiC31-int, attB-CMV-Neo and CMV-attP-DsRed2). Lane 9: negative control without vector. Lane 10: negative control of PCR. C) PCR DsRed2 results after restriction enzyme treatment. Lanes are similar to figure B. D) Nested PCR from the product isolated from lane 6 to confirm the specificity of PCR DsRed2 amplification.
Figure 5 Detection of recombination mediated by phiC31-int between an attB site contained into a NILV and a genomic attP site. A) Scheme of the DsRed2 PCR before and after the enzymatic restriction treatment. B) PCR DsRed2 results without restriction enzyme treatment. Lanes 1 to 3: cotransduction with CMV-Neo and CMV-PhiC31 increasing vector input of 50–150–300 ng of p24. Lanes 4 to 6: cotransduction with attB-CMV-Neo and CMV-PhiC31 increasing vector input of 50–150–300 ng of p24. Lane 7: attB-CMV-Neo. Lane 8: positive control generated by triple-transfection (CMV-phiC31-int, attB-CMV-Neo and CMV-attP-DsRed2). Lane 9: negative control without vector. Lane 10: negative control of PCR. C) PCR DsRed2 results after restriction enzyme treatment. Lanes are similar to figure B. D) Nested PCR from the product isolated from lane 6 to confirm the specificity of PCR DsRed2 amplification.CC BY · PubMed Central
Figure 6 Effect of NLS sequence on phiC31-int activity in NILV context. A) Cotransduction of NILVs CMV-PhiC31 and CMV-Neo or attB-CMV-Neo. Four p24 doses of PhiC31 vector were used (D1: 3 ng, D2: 5 ng, D3: 10 ng, D4: 33 ng). B) Cotransduction of NILVs CMV-PhiC31-NLS and CMV-Neo or attB-CMV-Neo. Four p24 doses of PhiC31 vector were used (D1: 3 ng, D2: 5 ng, D3: 10 ng, D4: 33 ng). No significant differences are observed between sample with or without attB sequence in the vector pTRIP-CMV-Neo. Satistics: two ways ANOVA with Bonferroni posttest (Prism 5).
Figure 6 Effect of NLS sequence on phiC31-int activity in NILV context. A) Cotransduction of NILVs CMV-PhiC31 and CMV-Neo or attB-CMV-Neo. Four p24 doses of PhiC31 vector were used (D1: 3 ng, D2: 5 ng, D3: 10 ng, D4: 33 ng). B) Cotransduction of NILVs CMV-PhiC31-NLS and CMV-Neo or attB-CMV-Neo. Four p24 doses of PhiC31 vector were used (D1: 3 ng, D2: 5 ng, D3: 10 ng, D4: 33 ng). No significant differences are observed between sample with or without attB sequence in the vector pTRIP-CMV-Neo. Satistics: two ways ANOVA with Bonferroni posttest (Prism 5).CC BY · PubMed Central
Figure 7 Hypothetical model to explain the inversion of 4.8 Step 1: Integration of a NILV mediated by phiC31-int into a pattP site. Step2: Recombination mediated by phiC31-int between the pattL generated during step 1 and another patt site located at 4 kb.
Figure 7 Hypothetical model to explain the inversion of 4.8 Step 1: Integration of a NILV mediated by phiC31-int into a pattP site. Step2: Recombination mediated by phiC31-int between the pattL generated during step 1 and another patt site located at 4 kb.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Research works printed but not linked: 1

  1. B Moldt, 2008, Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase, BMC Biotechnol, 8, 60, 10.1186/1472-6750-8-60 · DOI · Paper page

Cited by

See all 11

Metadata

Authors
Grandchamp, N., Altémir, D., Philippe, S., Ursulet, S., Pilet, H., Serre, M.-C., Lenain, A., Serguera, C., Mallet, J., & Sarkis, C.
Affiliations
  • Inserm (FR)
  • Laboratoire de Virologie Moléculaire et Structurale (FR)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
Corresponding author
Sarkis, Chamsy
Venue
PLoS ONE
Published
2014-06-23
Volume
9
Issue
6
Pages
e99649
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1983795781
Cited by
11
References
98
Citations by year
2026: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 1
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
lentiviral vectors, phiC31 integrase, site-specific recombination, attP site, attB site, DNA damage, insertional mutagenesis, transgenesis, stable gene expression
MeSH terms
Animals, Attachment Sites, Microbiological, Bacteriophages, Base Sequence, Cell Line, DNA Damage, Genetic Vectors, Humans, Hybridization, Genetic, Models, Biological, Molecular Sequence Data, Recombination, Genetic, Lentivirus, Polymerase Chain Reaction, Mutagenesis, Insertional, Nuclear Localization Signals, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage. https://app.cochat.ai/papers/10.1371/journal.pone.0099649
The paper
Grandchamp, N., Altémir, D., Philippe, S., Ursulet, S., Pilet, H., Serre, M.-C., Lenain, A., Serguera, C., Mallet, J., & Sarkis, C. (2014). Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage. PLoS ONE. https://doi.org/10.1371/journal.pone.0099649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.